Article 10 Jan 2018 Amgen Moves To Dismiss Genentech's Misrepresentation Claim United States Healthcare
Article 12 Jul 2016 Apotex—Biosimilars Must Provide 180-Day Marketing Notice After FDA Approval United States Healthcare